JNJ vs WST
By Alex · Tickerpine
Johnson & Johnson vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | WST |
|---|---|---|
| Price | $273.14 | $348.48 |
| Market cap | $658.24B | $24.52B |
| P/E ratio | 31.7 | 45.3 |
| ROE | 25.74% | 19.09% |
| Profit margin | 21.48% | 16.98% |
| Revenue growth | 6.60% | 13.80% |
| Dividend yield | 1.96% | 0.25% |
| Beta | 0.23 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs WST in plain English
- JNJ is the bigger company — about 26.8× the market cap of WST.
- JNJ is cheaper on earnings (P/E 31.7 vs 45.3).
- JNJ earns a higher return on equity (26% vs 19%).
- WST is growing revenue faster (14% vs 7%).
- JNJ has the higher dividend yield (1.96% vs 0.25%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.